24 results for “switzerland”
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after Switzerland announced […]
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
Cannavigia’s COO and co-founder, Philipp Hagenbach, shares his thoughts on Switzerland’s approach to cannabis reform.
Swiss company Cannavigia is supporting the pilot with its track and trace software.
Astrasana and Clever Leaves have partnered to establish an international supply agreement for medical cannabis extracts in Czech Republic and Switzerland. Clever Leaves Holdings Inc, a global medicinal cannabis company, […]
Thousands of Swiss residents have access to legal adult-use cannabis, while patients say they are still struggling to get prescriptions.
Vigia AG is creating transparency and trust in the supply of the first legally sold cannabis in Switzerland.
The company has been granted a licence for the production of high-THC active pharmaceutical ingredients (APIs) by Swissmedic.
Europe’s first trial of adult-use THC cannabis is expected to begin in the new year, Swiss officials have confirmed. Switzerland’s so-called ‘Weed Care’ trial, the first pilot program to study […]
Switzerland’s Council of States has voted to allow doctors to prescribe medical cannabis directly to patients. The Council of States voted unanimously to allow cannabis-based medicines to be directly prescribed […]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in […]
The international patient-led organisation We, The Patients, will bring its educational series to London next month.
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to cannabis. Europe’s first adult-use […]
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which permits them to purchase medical cannabis from any legal dispensary.
The event will focus on the medicinal use of cannabis in chronic neurodegenerative diseases.
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of the Citizens’ Assembly.
A new study, based on the experiences of endometriosis patients in Europe, has found cannabis to have a significant impact on wellbeing and quality of life.
The charity is hoping to raise £50,000 to support its work in bringing “responsible cannabis regulation” to the UK.
The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business of Cannabis. It came […]
The first data collected from the Grashaus Project in the canton of Basel-Landschaft has been published.
We asked experts in the European cannabis sector about their predictions for 2024.
